Amicus Therapeutics (FOLD) Interest & Investment Income (2016 - 2025)
Amicus Therapeutics (FOLD) has disclosed Interest & Investment Income for 16 consecutive years, with $833000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 41.17% year-over-year to $833000.0, compared with a TTM value of $3.3 million through Dec 2025, down 38.65%, and an annual FY2025 reading of $3.3 million, down 38.65% over the prior year.
- Interest & Investment Income was $833000.0 for Q4 2025 at Amicus Therapeutics, roughly flat from $829000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.2 million in Q1 2023 and bottomed at $50000.0 in Q2 2021.
- Average Interest & Investment Income over 5 years is $966750.0, with a median of $838000.0 recorded in 2025.
- The sharpest move saw Interest & Investment Income tumbled 94.22% in 2021, then soared 1553.38% in 2023.
- Year by year, Interest & Investment Income stood at $186000.0 in 2021, then skyrocketed by 960.22% to $2.0 million in 2022, then decreased by 15.26% to $1.7 million in 2023, then fell by 15.26% to $1.4 million in 2024, then crashed by 41.17% to $833000.0 in 2025.
- Business Quant data shows Interest & Investment Income for FOLD at $833000.0 in Q4 2025, $829000.0 in Q3 2025, and $843000.0 in Q2 2025.